220 related articles for article (PubMed ID: 17724283)
21. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
Yates R; Nairn K; Dixon R; Kemp JV; Dane AL
J Clin Pharmacol; 2002 Nov; 42(11):1244-50. PubMed ID: 12412823
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.
Matharu MS; Levy MJ; Meeran K; Goadsby PJ
Ann Neurol; 2004 Oct; 56(4):488-94. PubMed ID: 15455406
[TBL] [Abstract][Full Text] [Related]
23. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
[TBL] [Abstract][Full Text] [Related]
24. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray--an open pilot study.
Schuh-Hofer S; Reuter U; Kinze S; Einhäupl KM; Arnold G
J Neurol; 2002 Jan; 249(1):94-9. PubMed ID: 11954875
[TBL] [Abstract][Full Text] [Related]
25. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.
Solomon GD; Cady RK; Klapper JA; Earl NL; Saper JR; Ramadan NM
Neurology; 1997 Nov; 49(5):1219-25. PubMed ID: 9371897
[TBL] [Abstract][Full Text] [Related]
27. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study.
Gawel M; Aschoff J; May A; Charlesworth BR;
J Headache Pain; 2005 Oct; 6(5):405-11. PubMed ID: 16362714
[TBL] [Abstract][Full Text] [Related]
28. Triptans for acute cluster headache.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD008042. PubMed ID: 24353996
[TBL] [Abstract][Full Text] [Related]
29. Is oral zolmitriptan efficacious in the acute treatment of cluster headache?
Encarnacion JR; Ellis MR; Lindbloom EJ
J Fam Pract; 2000 Sep; 49(9):784, 849. PubMed ID: 11032200
[No Abstract] [Full Text] [Related]
30. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
McKeage K
Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Spierings EL; Brandes JL; Kudrow DB; Weintraub J; Schmidt PC; Kellerman DJ; Tepper SJ
Cephalalgia; 2018 Feb; 38(2):215-224. PubMed ID: 29022755
[TBL] [Abstract][Full Text] [Related]
32. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers.
Yates R; Nairn K; Dixon R; Seaber E
J Clin Pharmacol; 2002 Nov; 42(11):1237-43. PubMed ID: 12412822
[TBL] [Abstract][Full Text] [Related]
33. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
34. Triptans for acute cluster headache.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2010 Apr; (4):CD008042. PubMed ID: 20393964
[TBL] [Abstract][Full Text] [Related]
35. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
Mauskop A; Farkkila M; Hering-Hanit R; Rapoport A; Warner J
Curr Med Res Opin; 1999; 15(4):282-9. PubMed ID: 10640260
[TBL] [Abstract][Full Text] [Related]
36. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
[TBL] [Abstract][Full Text] [Related]
37. Intranasal zolmitriptan for the treatment of acute migraine.
Tepper SJ; Chen S; Reidenbach F; Rapoport AM
Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
[TBL] [Abstract][Full Text] [Related]
38. A long-term study to maximise migraine relief with zolmitriptan.
Tepper SJ; Donnan GA; Dowson AJ; Bomhof MA; Elkind A; Meloche J; Fletcher PE; Millson DS
Curr Med Res Opin; 1999; 15(4):254-71. PubMed ID: 10640258
[TBL] [Abstract][Full Text] [Related]
39. [Intranasal zolmitriptan acts quickly].
Ziegler R
Med Monatsschr Pharm; 2007 Mar; 30(3):121-2. PubMed ID: 17405495
[No Abstract] [Full Text] [Related]
40. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
